Merck Acquires Chinese AI Follicle Tracking Startup to Enhance Digital Fertility Ecosystem
Pharmaceutical giant Merck has acquired a Shenzhen-based AI ultrasound startup for an undisclosed sum. The startup’s software utilizes deep learning to automate follicle counting and measurement, integrating directly with electronic medical records (EMR) to optimize hormone dosage recommendations in real-time.
Business Insight: Big pharma is moving beyond simply selling stimulation drugs; they are acquiring software to control the entire clinical workflow. Building interoperable SaaS platforms that connect diagnostics to drug administration is the ultimate exit strategy for med-tech startups in 2026. Equipment vendors and software developers at CMTF are highly attractive acquisition targets for global strategics.
【Keywords】: #MergersAndAcquisitions #AIFollicleTracking #DigitalHealth
